Enhanced tumor cell killing in the presence of ganciclovir by herpes simplex virus type 1 vector-directed coexpression of human tumor necrosis factor-α and herpes simplex virus thymidine kinase

Cancer Research

Volumn 58, Issue 24, 1998, Pages 5731-5737

  Moriuchi, Shusuke ^a   Oligino, Thomas ^a   Krisky, David ^a   Marconi, Peggy ^a   Fink, David ^a   Cohen, Justus ^a   Glorioso, Joseph C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GANCICLOVIR; PROTEIN; THYMIDINE KINASE; TUMOR NECROSIS FACTOR ALPHA; VIRUS VECTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL KILLING; CELL PROLIFERATION; CERCOPITHECIDAE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE THERAPY; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR; VERO CELL;

ANIMALS; CERCOPITHECUS AETHIOPS; DRUG RESISTANCE, NEOPLASM; EVALUATION STUDIES; GENE THERAPY; GENETIC VECTORS; GLIOBLASTOMA; HERPESVIRUS 1, HUMAN; HUMANS; MICE; MICE, NUDE; THYMIDINE KINASE; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032535495     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Culver, K. M., Ram, Z., Walbridge, S., Ishii, H., Oldfield, E. H., and Blaese, R. M. In vivo gene transfer with retroviral vector-producing cells for treatment of experimental brain tumors. Science (Washington DC), 256: 1550-1552, 1992.
2. Barba, D., Hardin, J., Ray, J., and Gage, F. H. Thymidine kinase-mediated killing of rat brain tumors. J. Neurosurg., 79: 729-735, 1993.
3. Barba, D., Hardin, J., Sadelain, M., and Gage, F. H. Development of antitumor immunity for following thymidine kinase-mediated killing of experimental brain tumors. Proc. Natl. Acad. Sci. USA, 91: 4348-4352, 1994.
4. Ram, Z., Culver, K. W., Oshiro, E. M., Viola, J. J., DeVroom, H. L., Otto, E., Long, Z., Chiang, Y., McGarrity, G. J., Muul, L. M., Katz, D., Blaese, R. M., and Oldfield, E. H. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat. Med., 12: 1354-1361, 1997.
5. Okada, H., Miyamura, K., Itoh, T., Hagiwara, M., Wakabayashi, T., Mizuno, M., Colosi, P., Kurtzman, G., and Yoshida, J. Gene therapy against an experimental glioma using adeno-associated virus vectors. Gene Ther., 3: 957-964, 1996.
6. Chen, S. H., Shine, H. D., Goodman, J. C., Grossman, R. G., and Woo, S. L. Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA, 91: 3054-3057, 1994.
7. Perez-Cruet, M. J., Trask, T. W., Chen, S. H., Goodman, J. C., Woo, S. L., Grossman, R. G., and Shine, H. D. Adenovirus-mediated gene therapy of experimental gliomas. J. Neurosci. Res., 39: 506-511, 1994.
8. Vincent, A. J., Vogels, R., Someren, G. V., Esandi, M. C., Noteboom, J. L., Avezaat, C. J., Vecht, C., Bekkum, D. W., Valerio, D., Bout, A., and Hoogerbrugge, P. M. Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors. Hum. Gene Then, 7: 197-205, 1996.
9. Vincent, A. J., Esandi, M. C., Avezaat, C. J., Vecht, C. J., Sillevis S. P., van Bekkum, D. W., Valerio, D., Hoogerbrugge, P. M., and Bout, A. Preclinical testing of recombinant adenoviral herpes simplex virus-thymidine kinase gene therapy for central nervous system malignancies. Neurosurgery, 41: 442-452, 1997.
10. Boviatsis, E. J., Park, J. S., Sena-Esteves, M., Kramm, C. M., Chase, M., Efird, J. T., Wei, M. X., Breakfield, X. O., and Chiocca, E. A. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res., 54: 5745-5751, 1994.
11. Yamasaki, H., and Katoh, F. Further evidence for the involvement of gap-junctional intercellular communication in induction and maintenance of transformed foci in BALB/c 3T3 cells. Cancer Res., 48: 3490-3495, 1988.
12. Freeman, S. M., Abbound, C. N., Whartenby, K. A., Packman, C. H., Koeplin, D. S., Moolten, F. L., and Abranham, G. N. The bystander effect: tumor regression when a fraction of the tumor mass is genetically modified Cancer Res., 53: 5274-5283, 1993.
13. Wu, J., Cano, W. G., Meylaerts, S. A., Qi, P., Vrionis, F., and Cherington, V. Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery, 35: 1094-1102, 1994.
14. Bi, W. L., Parysek, L. M., Warnick, R., and Stambrook, P. J. In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HCV TK retroviral gene therapy. Hum. Gene Ther., 4: 725-731, 1993.
15. Mesnil, M., Piccoli, C., Tiraby, G., Willecke, K., and Yamasaki, H. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc. Natl. Acad. Sci. USA, 93: 1831-1835, 1996.
16. Han, S. K., Brody, S. L., and Crystal, R. G. Suppression of in vivo tumorigenicity of human lung cancer cells by retrovirus-mediated transfer of the human tumor necrosis factor-α cDNA. Am. J. Resp. Cell. Mol. Biol., 11: 270-278, 1994.
17. Cao, G., Kuriyama, S., Du, P., Sakamoto, T., Kong, X., Masui, K., and Qi, Z. Complete regression of established murine hepatocellular carcinoma by in vivo tumor necrosis factor a gene transfer. Gastroenterology, 112: 501-510, 1997.
18. Pfizenmaier, K., Pfizenmaier, K., Scheurich, P., Schluter, C., and Kronke, M. Tumor necrosis factor enhances HLA-A, B, C and HLA-DR gene expression in human tumor cells. J. Immunol., 138: 975-980, 1987.
19. Rothlein, R., Czajkowski, M., O'Neill, M. M., Martin, S. D., and Merluzzi, V. J. Induction of intercellular adhesion molecule 1 on primary and continuous cell lines by pro-inflammatory cytokines. Regulation by pharmacologic agents and neutralizing antibodies. J. Immunol., 141: 1665-1669, 1988.
20. Plaetinck, G., Declercq, W., Tavemier, J., Jabholz, M., and Fiers, W. Recombinant tumor necrosis factor can induce interleukin 2 receptor expression and cytolytic activity in a rat x mouse T cell hybrid. Eur. J. Immunol., 17: 1835-1838, 1987.
21. Ostensen, M. E., Thiele, D. L., and Lipsky, P. E. Enhancement of human natural killer cell function by the combined effects of tumor necrosis factor α or interleukin-I and interferon-α or interleukin-2. J. Biol. Res. Mod., 8: 53-61, 1987.